Skip to main content

Table 2 Biomarkers of female and male COVID-19 patients and controls as reported in SDY1648

From: CIDO ontology updates and secondary analysis of host responses to COVID-19 infection based on ImmPort reports and literature

Gene ID Gene Name Significant Difference between Diseased & Healthy in the Same Sexa Significant Difference in Female/male Patienta After Adjustments Significant Difference in Female/male in Healtha After Adjustments
1435 CSF1 colony stimulation factor 1 Both - (Female) - (Female)
1440 CSF3 colony stimulating factor 3 Female - (Male) - (Male)
3440 IFNa2 interferon alpha2 Both - (Female) - (Male)
3458 IFNG interferon gamma Female - (Female) - (Male)
3557 IL-1RA interleukin 1 receptor antagonist Both - (Male) - (Male)
3569 IL-6 Interleukin-6 Both - (Male) - (Female)
3606 IL-18 Interleukin-18 Female - (Male) - (Male)
3576 CXCL8 (IL8) C-X-C motif chemokine ligand 8 Female - (Male) - (Female)
3627 CXCL10 C-X-C motif chemokine ligand 10 Both - (Male) - (Female)
6351 CCL4 C-C motif chemokine ligand 4 Male - (Male) - (Female)
6352 CCL5 C-C motif chemokine ligand 5 Both - (Male) - (Female)
  1. a Statistically significant difference in female, male, or both female or male after adjusting for BMI and age. Terms in parenthesis indicates which was greater